Carbonic Anhydrase XII Inhibitors Overcome P-Glycoprotein-Mediated Resistance to Temozolomide in Glioblastoma. 2018

Iris C Salaroglio, and Prashant Mujumdar, and Laura Annovazzi, and Joanna Kopecka, and Marta Mellai, and Davide Schiffer, and Sally-Ann Poulsen, and Chiara Riganti
Department of Oncology, University of Torino, Torino, Italy.

The role of carbonic anhydrase XII (CAXII) in the chemoresistance of glioblastoma is unexplored. We found CAXII and P-glycoprotein (Pgp) coexpressed in neurospheres derived from 3 of 3 patients with different genetic backgrounds and low response to temozolomide (time to recurrence: 6-9 months). CAXII was necessary for the Pgp efflux of temozolomide and second-line chemotherapeutic drugs, determining chemoresistance in neurospheres. Psammaplin C, a potent inhibitor of CAXII, resensitized primary neurospheres to temozolomide by reducing temozolomide efflux via Pgp. This effect was independent of other known temozolomide resistance factors present in the patients. The overall survival in orthotopic patient-derived xenografts of temozolomide-resistant neurospheres, codosed with Psammaplin C and temozolomide, was significantly increased over temozolomide-treated (P < 0.05) and untreated animals (P < 0.02), without detectable signs of systemic toxicity. We propose that a CAXII inhibitor in combination with temozolomide may provide a new and effective approach to reverse chemoresistance in glioblastoma stem cells. This novel mechanism of action, via the interaction of CAXII and Pgp, ultimately blocks the efflux function of Pgp to improve glioblastoma patient outcomes.

UI MeSH Term Description Entries
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D002256 Carbonic Anhydrases A family of zinc-containing enzymes that catalyze the reversible hydration of carbon dioxide. They play an important role in the transport of CARBON DIOXIDE from the tissues to the LUNG. EC 4.2.1.1. Carbonate Dehydratase,Carbonic Anhydrase,Anhydrases, Carbonic,Dehydratase, Carbonate
D002257 Carbonic Anhydrase Inhibitors A class of compounds that reduces the secretion of H+ ions by the proximal kidney tubule through inhibition of CARBONIC ANHYDRASES. Carbonate Dehydratase Inhibitor,Carbonate Dehydratase Inhibitors,Carbonic Anhydrase Inhibitor,Carboxyanhydrase Inhibitor,Carboxyanhydrase Inhibitors,Anhydrase Inhibitor, Carbonic,Dehydratase Inhibitor, Carbonate,Inhibitor, Carbonate Dehydratase,Inhibitor, Carbonic Anhydrase,Inhibitor, Carboxyanhydrase,Inhibitors, Carbonate Dehydratase,Inhibitors, Carbonic Anhydrase,Inhibitors, Carboxyanhydrase
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D005260 Female Females
D005909 Glioblastoma A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures. Astrocytoma, Grade IV,Giant Cell Glioblastoma,Glioblastoma Multiforme,Astrocytomas, Grade IV,Giant Cell Glioblastomas,Glioblastoma, Giant Cell,Glioblastomas,Glioblastomas, Giant Cell,Grade IV Astrocytoma,Grade IV Astrocytomas

Related Publications

Iris C Salaroglio, and Prashant Mujumdar, and Laura Annovazzi, and Joanna Kopecka, and Marta Mellai, and Davide Schiffer, and Sally-Ann Poulsen, and Chiara Riganti
April 2019, Journal of medicinal chemistry,
Iris C Salaroglio, and Prashant Mujumdar, and Laura Annovazzi, and Joanna Kopecka, and Marta Mellai, and Davide Schiffer, and Sally-Ann Poulsen, and Chiara Riganti
December 2016, Oncotarget,
Iris C Salaroglio, and Prashant Mujumdar, and Laura Annovazzi, and Joanna Kopecka, and Marta Mellai, and Davide Schiffer, and Sally-Ann Poulsen, and Chiara Riganti
November 2022, Journal of medicinal chemistry,
Iris C Salaroglio, and Prashant Mujumdar, and Laura Annovazzi, and Joanna Kopecka, and Marta Mellai, and Davide Schiffer, and Sally-Ann Poulsen, and Chiara Riganti
January 2021, Cancer drug resistance (Alhambra, Calif.),
Iris C Salaroglio, and Prashant Mujumdar, and Laura Annovazzi, and Joanna Kopecka, and Marta Mellai, and Davide Schiffer, and Sally-Ann Poulsen, and Chiara Riganti
December 2021, International journal of molecular sciences,
Iris C Salaroglio, and Prashant Mujumdar, and Laura Annovazzi, and Joanna Kopecka, and Marta Mellai, and Davide Schiffer, and Sally-Ann Poulsen, and Chiara Riganti
October 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Iris C Salaroglio, and Prashant Mujumdar, and Laura Annovazzi, and Joanna Kopecka, and Marta Mellai, and Davide Schiffer, and Sally-Ann Poulsen, and Chiara Riganti
September 2016, Expert opinion on drug metabolism & toxicology,
Iris C Salaroglio, and Prashant Mujumdar, and Laura Annovazzi, and Joanna Kopecka, and Marta Mellai, and Davide Schiffer, and Sally-Ann Poulsen, and Chiara Riganti
January 2008, Current medicinal chemistry,
Iris C Salaroglio, and Prashant Mujumdar, and Laura Annovazzi, and Joanna Kopecka, and Marta Mellai, and Davide Schiffer, and Sally-Ann Poulsen, and Chiara Riganti
March 2015, Oncotarget,
Iris C Salaroglio, and Prashant Mujumdar, and Laura Annovazzi, and Joanna Kopecka, and Marta Mellai, and Davide Schiffer, and Sally-Ann Poulsen, and Chiara Riganti
February 2022, Nanomedicine : nanotechnology, biology, and medicine,
Copied contents to your clipboard!